Mitigating the spread of COVID-19 during extubation: Assessing the impact of a barrier device.
Perioper Care Oper Room Manag
; 29: 100289, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2049735
ABSTRACT
COVID-19 is a novel virus spread via airborne particles. Given the inherent risk to the anesthesia provider, intubation and airway management guidelines have been recently established. Various studies have been published advocating and detailing the results of different intubation devices designed to decrease the number of airborne particles. Currently, little literature exists regarding devices designed to mitigate the spread of COVID-19 airborne particles during extubation. The purpose of this prospective in situ simulated manikin study was to measure the effectiveness of an aerosolized containment device during passive (deep) and forced (simulated coughing) extubation. Airborne particles were measured at the 0.3, 0.5, 1, 2, 5, 10-micron level. Statistically significant decreases were seen with the use of a barrier device during both passive and forced extubation.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Language:
English
Journal:
Perioper Care Oper Room Manag
Year:
2022
Document Type:
Article
Affiliation country:
J.pcorm.2022.100289
Similar
MEDLINE
...
LILACS
LIS